OR WAIT null SECS
Attendees meet to discuss operational issues related to traceability implementation.
The recent Healthcare Distribution Alliance (HDA) Seminar held a session that has been popular at previous events—a roundtable—hosted by industry experts in the space. More specifically, it revolved heavily around six aspects that tie directly back to the Drug Supply Chain Security Act (DSCSA), including:
I sat in on topics number one, five, and six. All of the above topics intersect with sessions that Pharma Commerce attended, but if I had to narrow details down to one topic/table, it would be the barcoding, scanning issues, and RFID.
Gorniak’s discussion revolved around pharma RFID testing that has been underway at the Axia Institute/Michigan State University, featuring participating from Cencora, Zebra Technologies, and Fresenius Kabi. Results of the whitepaper are expected to be released soon, but it essentially tested RFID as an alternative to 2D scanning. According to Gorniak, RFID has the potential to read through liquid and blister packs, jumping “leaps and bounds” since 2013.
Sean Murphy, Cencora’s manager of manufacturer operations, stepped in to discuss barcodes—attendees alluded to the code quality of 2Ds, while expressing frustration over different colored barcodes; as an alternative, barcodes, Murphy said, should only be black and white as to not compromise quality.
Be sure to catch the rest of the Traceability Seminar coverage—including sessions related to the above topics—here.